##semicolon##
Monoooksigenaza, siklooksigenaza ingibitorlari, voltaren, dekstran, toksik gepatit, araxidon kislotasi##submission.citations##
1. Ноговицина, Е. А. Патологическая физиология. Раздел «Частная патологическая физиология» [Текст]: учеб. пособие / Е. А. Ноговицина. – Челябинск: ФГБОУ ВО Южно-Уральский ГАУ, 2021. – 94 с.
2. Tanasescu MD, Rosu AM, Minca A, Rosu AL, Grigorie MM, Timofte D, Ionescu D. Metabolic Dysfunction at the Core: Revisiting the Overlap of Cardiovascular, Renal, Hepatic, and Endocrine Disorders. Life (Basel). 2026 Jan 20;16(1):172. doi: 10.3390/life16010172.
3. Zhang, M., Liu, J., Yu, Y., Liu, X., Shang, X., Du, Z., Xu, M. L., & Zhang, T. Recent advances in the inhibition of membrane lipid peroxidation by food-borne plant polyphenols via the Nrf2/GPx4 pathway. Journal of Agricultural and Food Chemistry, 2024.- 72(22), 12340–12355. https://doi.org/10.1021/acs. jafc.4c00523.
4. Zheng, Y., Sun, J., Luo, Z., Li, Y., & Huang, Y. Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications. Cell Death & Disease, 2024.-15, 859. https://doi. org/10.1038/s41419-024-07244-x.
5. Zhou, Z., Huang, Z., Tang, Y., Zhu, Y., & Li, J. Modulating membrane-bound enzyme activity with chemical stimuli. European Journal of Medicinal Chemistry, 2024.-280, 116964. https://doi.org/10. 1016/j.ejmech.2024.116964.
6. Zhu, R., Wu, C., Zha, J., Lu, S., & Zhang, J. Decoding allosteric landscapes: computational methodologies for enzyme modulation and drug discovery. RSC Chemical Biology, 2025.- 6, 539–554. https:// doi.org/10.1039/D4CB00282B
7. Xarkevich D.A. Farmakologiy. – Moskva: GEOTAR-Media, 2021. – 908 b.
8. Lebedev, S. S., Tavobilov, M. M., Karpov, A. A., Abramov, K. A., Bochkov, P. O., Shevchenko, R. V., Denisenko, N. P., Shabunin, A. V., & Sychev, D. A. Cytochrome P450 3A4 activity and genetic variants as predictors of liver failure in patients with obstructive jaundice. Free Radical Biology and Medicine, 2023.- 208, 229–235. https://doi.org/10.1016/j.freeradbiomed.2023.08.012.
9. Ramírez-Mejía, M. M., Castillo-Castañeda, S. M., Pal, S. C., Qi, X., & Méndez-Sánchez, N. The multifaceted role of bilirubin in liver disease: A literature review. Journal of Clinical and Translational Hepatology, 2024.-12(11), 939–948. https://doi.org/10.142 18/JCTH.2024.00156.
10. Mokhosoev, I. M., Astakhov, D. V., Terentiev, A. A., & Moldogazieva, N. T. Cytochrome P450 monooxygenase systems: Diversity and plasticity for adaptive stress response. Progress in Biophysics and Molecular Biology, 2024.- 193, 19–34. https://doi. org/10.1016/j.pbiomolbio.2024.09.003.
11. Li, S., Wang, B., Zhang, M., Yin, Q., Yang, Z., Li, X., & Liang, G. Induction of cytochrome P450 via upregulation of CAR and PXR: a potential mechanism for altered drug metabolism. Frontiers in Pharmacology, 2024.- 15, 1460948. https://doi.org/10.3389/ fphar.2024.1460948.
12. Chatzipieris FP, Petsas E, Lambrinidis G, Vassiliou S, Chasapis CT. Recent Advances in Dual COX/LOX Inhibitor Design (2020-2024): Establishing "The Rule of Four for Inflammation". Life (Basel). 2026 Jan 19;16(1):163. doi: 10.3390/life16010163.
13. Silva-Velasco, D. L., Cervantes-Pérez, L. G., & Sánchez-Mendoza, A. ACE inhibitors and their interaction with systems and molecules involved in metabolism. Heliyon, 2024.- 10(2), e24655. https://doi. org/10.1016/j.heliyon.2024.e24655.
14. Zhang, X., Hu, C., Tian, E., Shen, Y., Liu, W., & Li, J. Comprehensive review on neprilysin (NEP) inhibitors: design, structure–activity relationships, and clinical applications. Frontiers in Pharmacology, 2024.- 15, 1501407. https://doi.org/10.3389/fphar. 2024.1501407/
15. Erjiao Qiang, Hu Xu, PGE2 synthesis and signaling in the liver physiology and pathophysiology: An update, Prostaglandins & Other Lipid Mediators, Volume 174, 2024.- 106875, ISSN 1098-8823, https://doi.org/10.1016/j.prostaglandins.2024.106875.
16. Li, X., Xu, X., Lai, W., Jiang, A., Zhou, N., & Yu, Y. Prostanoids in liver repair and regeneration: Biosynthesis, receptors, and intercellular communication. Cellular and Molecular Gastroenterology and Hepatology, 2026.- 20(1), 101645. https://doi.org/ 10.1016/j.jcmgh.2025.101645.
17. Lin, Z.-Q., Yao, Y., Zhang, Y.-F., Zhang, X.-Y., & Guan, Y.-F. Role of prostaglandin E₂ and its receptors in chronic liver disease. Sheng Li Xue Bao, 2024.- 76(2), 329–340.
18. Yue, J., Tan, Y., Huan, R., Guo, J., Yang, S., Deng, M., Xiong, Y., Han, G., Liu, L., Liu, J., Cheng, Y., Zha, Y., & Zhang, J. Mast cell activation mediates blood–brain barrier impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway. Frontiers in Immunology, 2023.-14, 10902 88. https://doi.org/10.3389/fimmu.2023.1090288.
19. Harsh Kumar, Neetika Kimta, Sumeet Kapoor, Eugenie Nepovimova, Chirag Chopra, Tejas Suthar, Diana ´ Ungai, Kovacs ´ B´ela, Endre Harsanyi, Ayaz Mukarram Shaikh. Dietary antioxidants in mitigating carbon tetrachloride-induced hepatotoxicity: An integrative review of preclinical insights. Journal of Functional Foods, 2025.- 133, 107020. https:// doi.org/10.1016/j.jff.2025.107020,
20. Тao, L., Xue, Y.-F., Sun, F.-F., He, X., Wang, H.-Q., Tong, C.-C., Zhang, C., Xu, D.-X., & Chen, X. Mito Q protects against carbon tetrachloride-induced hepatocyte ferroptosis and acute liver injury by suppressing mtROS-mediated ACSL4 upregulation. Toxicology and Applied Pharmacology, 2024.- 486, 116 914. https://doi.org/10.1016/j.taap.2024.116914